Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Fodstad

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
Cancer Genetics and Cytogenetics|February 1, 1987
Chromosome 13 instability and esterase D expression in an osteosarcoma cell lineE Hovig, J O Winberg, O Fodstad, et al.
Neurosurgery|April 1, 1994
In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanomaW A Hall, A Myklebust, A Godal, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Preclinical phase II studies in human tumor lines: a European multicenter studyE Boven, B Winograd, O Fodstad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Expression of a novel factor, com1, in early tumor progression of breast cancerA H Ree, M M Pacheco, M Tvermyr, et al.
Cancer Research|February 15, 1994
Suppression of the neoplastic phenotype in vivo by an anti-ras ribozymeM Kashani-Sabet, T Funato, V A Florenes, et al.
Journal of Experimental Therapeutics & Oncology|March 1, 1996
Comparative antitumor activities of halichondrins and vinblastine against human tumor xenograftsO Fodstad, K Breistøl, G R Pettit, et al.
Cancer Genetics and Cytogenetics|November 1, 1991
Chromosome 13 alterations in osteosarcoma cell lines derived from a patient with previous retinoblastomaE Hovig, R Lothe, G Farrants, et al.
The American Journal of Pathology|September 1, 1992
Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methodsK Beiske, A T Myklebust, S Aamdal, et al.
Oncogene Research|January 1, 1989
Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomasJ Y Shew, N Ling, X M Yang, et al.
Anti-Cancer Drugs|March 1, 1997
Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparationK A Semb, O Fodstad, B Klem, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Cancer Genetics and Cytogenetics|February 1, 1987
Chromosome 13 instability and esterase D expression in an osteosarcoma cell lineE Hovig, J O Winberg, O Fodstad, et al.
Neurosurgery|April 1, 1994
In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanomaW A Hall, A Myklebust, A Godal, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Preclinical phase II studies in human tumor lines: a European multicenter studyE Boven, B Winograd, O Fodstad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Expression of a novel factor, com1, in early tumor progression of breast cancerA H Ree, M M Pacheco, M Tvermyr, et al.
Cancer Research|February 15, 1994
Suppression of the neoplastic phenotype in vivo by an anti-ras ribozymeM Kashani-Sabet, T Funato, V A Florenes, et al.
Journal of Experimental Therapeutics & Oncology|March 1, 1996
Comparative antitumor activities of halichondrins and vinblastine against human tumor xenograftsO Fodstad, K Breistøl, G R Pettit, et al.
Cancer Genetics and Cytogenetics|November 1, 1991
Chromosome 13 alterations in osteosarcoma cell lines derived from a patient with previous retinoblastomaE Hovig, R Lothe, G Farrants, et al.
The American Journal of Pathology|September 1, 1992
Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methodsK Beiske, A T Myklebust, S Aamdal, et al.
Oncogene Research|January 1, 1989
Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomasJ Y Shew, N Ling, X M Yang, et al.
Anti-Cancer Drugs|March 1, 1997
Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparationK A Semb, O Fodstad, B Klem, et al.
Pageof 17